12 Health Care Stocks Moving In Monday's After-Market Session
Portfolio Pulse from Benzinga Insights
Several healthcare stocks experienced significant movement in Monday's after-market session. Femasys, Pliant Therapeutics, Ontrak, Brainstorm Cell, 180 Life Sciences, and Matinas BioPharma Hldgs saw their stocks rise, while TransCode Therapeutics, Biophytis, NeuBase Therapeutics, Tivic Health Systems, Immix Biopharma, and Inozyme Pharma experienced a decline.
September 25, 2023 | 9:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Biophytis stock fell 8.18% to $1.46.
The fall in Biophytis' stock price suggests negative investor sentiment, potentially leading to further short-term losses.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
TransCode Therapeutics stock declined by 20.0% to $2.04 during Monday's after-market session.
The significant decline in TransCode Therapeutics' stock price indicates negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Femasys shares rose by 56.8% to $0.52 during Monday's after-market session.
The significant rise in Femasys' share price indicates positive investor sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Pliant Therapeutics stock rose 15.85% to $16.89.
The rise in Pliant Therapeutics' stock price suggests positive investor sentiment, potentially leading to further short-term gains.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100